Epidemiology and clinical outcome of chronic hepatitis B virus infection and metabolic dysfunction
- VernacularTitle:慢性HBV感染与代谢功能障碍的流行病学与临床转归
- Author:
Jiaofeng HUANG
1
;
Qi ZHENG
1
Author Information
- Publication Type:Journal Article
- Keywords: Hepatitis B Virus; Non-alcoholic Fatty Liver Disease; Metabolic Dysfunction||
- From: Journal of Clinical Hepatology 2024;40(3):453-456
- CountryChina
- Language:Chinese
- Abstract: Chronic hepatitis B virus （HBV） infection is a worldwide public health issue and a leading cause of liver fibrosis， liver cirrhosis， liver failure， and primary liver cancer in China. The incidence rate of nonalcoholic fatty liver disease （NAFLD） is gradually increasing with the improvement in the living standards of people and the changes in dietary structure. Population-based studies have found that HBV infection can influence the development of NAFLD， but the mechanism remains unknown. Hepatic steatosis can also influence the expression of HBV serum pathogenic indicators， and its combination with NAFLD and other metabolic dysfunction diseases can increase the risk of liver fibrosis， liver cirrhosis， and liver cancer. Chronic HBV infection is closely associated with metabolic dysfunction， and more studies are needed in the future to better understand related mechanisms， so as to provide a theoretical foundation for clinical diagnosis and treatment.
